Trial Profile
Evaluation of Safety and Efficacy of Topical Baricitinib Plus Excimer Light Versus Excimer Light Alone in Treatment in Non-Segmental Vitiligo
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 20 Jul 2023
Price :
$35
*
At a glance
- Drugs Baricitinib (Primary)
- Indications Vitiligo
- Focus Therapeutic Use
- 20 Jul 2023 New trial record